scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00345-015-1531-6 |
P698 | PubMed publication ID | 25782867 |
P50 | author | Shahrokh Shariat | Q7462263 |
P2093 | author name string | Marianne Schmid | |
Margit Fisch | |||
Luis A Kluth | |||
Armin Soave | |||
Michael Rink | |||
Oliver Engel | |||
Roland Dahlem | |||
Sven Peine | |||
P2860 | cites work | Cancer statistics, 2014 | Q27861018 |
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium | Q34094983 | ||
AB0 blood group and prognosis in patients with pancreatic cancer | Q34354138 | ||
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling | Q36419132 | ||
The Rh protein family: gene evolution, membrane biology, and disease association | Q37642606 | ||
ABO blood group and cancer | Q37787521 | ||
Biomolecular predictors of urothelial cancer behavior and treatment outcomes | Q37987066 | ||
ABO blood group: old dogma, new perspectives | Q38104553 | ||
Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition | Q38203883 | ||
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee | Q40831782 | ||
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy | Q43622475 | ||
ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancer | Q43879790 | ||
Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. | Q45904406 | ||
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy | Q46489162 | ||
Do blood groups have effect on prognosis of patients undergoing radical cystectomy? | Q51150690 | ||
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. | Q52839590 | ||
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. | Q54391399 | ||
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. | Q54448028 | ||
Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy. | Q54729569 | ||
Barrettʼs, blood groups and progression to oesophageal cancer | Q59342685 | ||
Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma | Q68053765 | ||
Rhesus D-phenotype does not provide prognostic information additional to TNM staging in gastric cancer patients | Q73847753 | ||
Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer | Q74320800 | ||
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma | Q83192683 | ||
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients | Q84072813 | ||
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma | Q84947425 | ||
Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy | Q87230245 | ||
P433 | issue | 11 | |
P921 | main subject | Radical cystectomy | Q111329312 |
P304 | page(s) | 1769-1776 | |
P577 | publication date | 2015-03-18 | |
P1433 | published in | World Journal of Urology | Q15750774 |
P1476 | title | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. | |
P478 | volume | 33 |
Q53175926 | AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study. |
Q64966406 | ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. |
Q49380161 | Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. |
Q28551903 | Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer |
Q41432872 | The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy |
Q48007072 | The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. |
Q49407223 | The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients |
Q53185271 | Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. |